Rainbow Childrens Medicare Ltd (RAINBOW) is currently trading at 1,271.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Rainbow Children’s Medicare Limited operates specialized hospitals focused on pediatric, maternal, obstetric, gynecology and fertility care, delivered through the Rainbow Children’s Hospital and BirthRight brands. Its model combines consultant-led multidisciplinary care, Level-4 neonatal intensive care, pediatric super-specialties, quaternary services and a hub-and-spoke network across 26 hospitals and six clinics. The company delivered strong operating growth in Q2 FY27 despite lower occupancy caused by rapid capacity additions. Revenue increased 23.2% year over year to INR 5,480.2 million, while inpatient discharges, outpatient consultations and deliveries rose 15%, 19% and 20%, respectively, indicating broad demand momentum across both hospital and maternity services. Mature hospitals remain the economic engine, contributing 73% of group revenue with 54% occupancy and 28% EBITDA margins in Q2 FY27. Emerging hospitals are scaling faster, with inpatient discharges rising 32% year over year, while new hospitals remain loss-making at a negative 16% EBITDA margin, creating a clear maturity-driven earnings profile. Rainbow Children’s Medicare Limited is moving beyond its established southern markets through acquisitions, new hospitals and planned projects in Gurugram, Indore, Mumbai, Pune, Coimbatore and Amaravati. Management’s roadmap targets more than 5,000 beds by FY32, although the pace of expansion increases execution, staffing, capital allocation and near-term margin risks.

Over the past 52 weeks, Rainbow Childrens Medicare Ltd has traded between a low of ₹1,008.75 and a high of ₹1,609.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Rainbow Childrens Medicare Ltd has a market capitalization of approximately 12,669.42. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Rainbow Childrens Medicare Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 42.44 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 12,669.42 Cr, Rainbow Childrens Medicare Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Rainbow Childrens Medicare Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Rainbow Childrens Medicare Ltd is 42.44. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Rainbow reported ARPOB of Rs 66,922 at mature hospitals in Q2 FY27. This was 13% higher than Rs 59,097 in Q2 FY26 and lower than Rs 71,444 in Q1 FY27.

Yes. Rainbow reported a living-donor liver transplant for a six-week-old infant weighing 2.9 kg at its Banjara Hills hospital. The infant received a 62-gram liver graft from the mother.

Rainbow reported occupancy of 45.3% in H1 FY27, compared with 46.3% in H1 FY26. Operational beds increased 20% to 1,886, while IP discharges increased 21% to 59,592; occupancy is calculated using weighted average operated beds.

Rainbow's EBITDA margin declined to 31.0% from 33.5% because total expenses rose 26.8%, compared with 23.2% revenue growth. Professional fees to doctors increased 32.0%, employee benefits rose 27.9%, and other expenses increased 29.4%.